Skip to main content

Psychedelic medicine pioneer exits MDMA biotech after regulatory blow

Doblin leaves Lykos Therapeutics board after work on treatment for PTSD suffered setback from FDA ruling

https://ift.tt/DrKWfO7

Comments

Popular posts from this blog